It helps with malaria, but it doesn't help with COVID-19.
The FDA has withdrawn permission for the emergency use of chloroquine and hydroxychloroquine
The US Food and Drug Administration (FDA) on June 15, 2020 recalled An "emergency use permit" allowing the use of chloroquine and hydroxychloroquine to treat some hospitalized COVID-19 patients.
The emergency use authorization (EUA) does not mean full FDA approval and is issued in conditions where the required clinical trials are impossible or impractical.
Clinical experience has shown that chloroquine and hydroxychloroquine cause serious side effects. Both the known and potential benefits of these drugs no longer outweigh the known and likely risks to permit their use. The Management of Advanced Biomedical Research and Development (Biomedical Advanced Research and Development Authority, BARDA) initiated the recall of drugs.
Chloroquine and hydroxychloroquine remain in clinical practice in the United States as antimalarial drugs, which are also used as a non-specific anti-inflammatory agent for autoimmune diseases.
Portal "Eternal youth" http://vechnayamolodost.ru